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n 2015, for the first time in history, Canadians aged 65 years and older formed a larger proportion of the population than those aged 14 years and younger. 1 As with other highincome countries that have undergone the epidemiologic transition, noncommunicable diseases are driving morbidity and mortality in Canada. 2 Previous studies have provided detailed insight into cause-specific patterns of disease in the Canadian population 3, 4 using broad summary estimates of population health, such as health-adjusted life expectancy. 5 However, a comprehensive historical account of health loss across diseases and injuries in Canada, through metrics such as disabilityadjusted life years, has not yet been reported. This type of information could help inform decision-making in Canada by providing a better understanding of the diseases and injuries driving health loss in this country.
The Global Burden of Disease (GBD) Study provides a unique platform enabling the examination of health status by country, synthesizing data on a set of 333 diseases and injuries by age and sex, comparable across time and among 195 countries and territories. The GBD Study also reports disabilityadjusted life years, a variable that summarizes both mortality and morbidity and is a useful metric for understanding the relative burden of specific diseases and injuries. The GBD Study accomplishes these activities through the efforts of more than 3000 collaborators from more than 135 countries, led by the Institute for Health Metrics and Evaluation at the University of Washington, Seattle. 6 The GBD estimates are being used to inform health policy in several countries, including the United States, the Philippines, India, New Zealand and the United Kingdom. [7] [8] [9] As such, the GBD Study's methodologic innovations could add value to estimates available from established national data systems.
Canadian GBD estimates of disease burden can be found online through the GBD data visualization tool and in supple-
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mentary tables of the GBD capstone publications, [10] [11] [12] 
Methods
The GBD Study uses comprehensive data and methods to summarize and compare disease burden by age, sex, country, cause and year. The methods of the GBD Study have been reported in detail elsewhere. [10] [11] [12] In brief, global, regional and national estimates for disease prevalence, incidence, mortality, years of life lost, years lived with disability, disability-adjusted life years, life expectancy and health-adjusted life expectancy were published in the 2016 capstone papers, along with detailed methods for each set of estimates. [10] [11] [12] All GBD methods, data, codes and estimates are publicly available through interactive tools and visualizations at the online Data Visualization Hub (https://vizhub. healthdata.org/gbd-compare/). The GBD methodology is updated annually and is compliant with the Guidelines for Accurate and Transparent Health Estimates Reporting (also known as GATHER). 13 Members of the author group for the current paper are all GBD collaborators.
Data sources
Data obtained for the GBD Study were identified through comprehensive reviews of published studies reporting data for specific conditions and risk factors, unpublished national sources, international databases and additional data sources provided by GBD collaborators. [10] [11] [12] The 2016 iteration of the GBD Study incorporated data for Canada from 619 data sources (available from http://ghdx.healthdata.org/gbd-2016/data-input-sources).
GBD cause hierarchy
For mortality and nonfatal outcomes, the GBD hierarchy is or ganized into 4 levels, which are mutually exclusive and collectively exhaustive. [10] [11] [12] Sixty-eight of these causes are sources of disability but not death, whereas 5 are causes of death but not disability. 12 Level 0 includes all causes. Level 1 causes represent 3 major categories: communicable, maternal, neonatal and nutritional diseases; noncommunicable diseases; and injuries. Level 2 includes 21 broad cause groups within the level 1 categories, such as cardiovascular disease and noncommunicable diseases. Level 3 includes individual causes within the level 2 groups, such as cerebrovascular disease within cardiovascular disease. Finally, level 4 of the hierarchy includes sub-causes for some level 3 causes, such as hemorrhagic stroke within cerebrovascular disease. Here, we generally present data from level 0 to level 2; in only a few instances are level 3 data presented, to increase clarity (e.g., for HIV/AIDS and tuberculosis).
Statistical analysis
Mortality and nonfatal health loss
We modelled mortality estimates for diseases and injuries using the Cause of Death Ensemble model (CODEm) 14 or custom models for certain diseases. Detailed methods for the modelling procedures for mortality are provided elsewhere. 10 In brief, CODEm generates mortality estimates for each location-year, age and sex, through a standardized model ling process that combines covariable selection and out-of-sample validity analyses. We modelled nonfatal diseases using Disease Modelling-MetaRegression II (DisMod-MR 2.1) 11 or custom models for certain diseases. DisMod-MR 2.1 uses Bayesian meta-regression to synthesize available data sources and produce internally consistent estimates of incidence, prevalence, remission and excess mortality. We estimated nonfatal sequelae and comorbidities separately for each age group, sex, location and year through microsimulation. We applied disability weights to nonfatal causes by severity, using the same weights as in the 2013 and 2015 iterations of the GBD Study.
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Years of life lost, years lived with disability and disabilityadjusted life years We calculated years of life lost as the sum of each death multiplied by a standard life expectancy at each age. 10 We calculated the standard life expectancy for all countries from the lowest observed risk of mortality in each 5-year age group within populations greater than 5 million, which was 86.6 years in 2016. We calculated years of life lived with disability by multiplying the prevalence of a sequela by the disability weight for the corresponding health state. 11 We calculated disability-adjusted life years as the sum of years of life lost and years lived with disability for each cause; this variable was the cause-specific burden of a disease or injury, accounting for life lost and disability. 12 We used the GBD time-invariant, world population age standard to calculate age-standardized rates for all measures. 15 Detailed descriptions of the methods used to calculate these measures of disease burden have been desribed elsewhere.
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Life expectancy
We calculated life expectancy using life tables that use age-and sex-specific mortality rates to calculate period life expectancy at birth and at different ages. 16 We calculated health-adjusted life expectancy using the Sullivan approach, which incorporates ageand sex-specific mortality rates, disease prevalence and associated disability weights for all disease sequelae, as well as comorbidity in the population.
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International comparisons
We used the GBD sociodemographic index, which summarizes per capita income, mean years of education in the population aged 15 and older, and total fertility rate to identify relevant comparator countries. 12 In this paper, we compared Canada with other countries in North America, Western Europe and Australasia in the top quintile of the 2016 sociodemographic index. 
Uncertainty intervals
We calculated uncertainty intervals for all estimates, taking a number of factors into account, such as adjustment, standardization and uncertainty in model parameters, depending on the estimate. When calculation of GBD estimates required multiple steps, the uncertainty associated with each step is propagated through the entire calculation. The 95% uncertainty intervals for all estimates are reported in the tables.
Ethics approval
Ethics approval was not sought because this study was a secondary data analysis of published results.
Results
Mortality and years of life lost
In 2016, the largest proportion of deaths was caused by noncommunicable diseases, with an estimate of 243 553 deaths (see Table  A1 More all-age years of life lost were accounted for by neoplasms (1 530 983) and cardiovascular diseases (987 044) than all other causes combined (Table A1 in Appendix 1). From 2006 to 2016, the rate of all-cause age-standardized years of life lost decreased by 12% to 8798 years of life lost per 100 000. During this period, the rates of age-standardized years of life lost for every level 2 cause decreased, except for mental and substance use disorders, which increased by 12% to 244 years of life lost per 100 000.
Years lived with disability and disability-adjusted life years
In 2016, there were 4 512 880 years lived with disability from all causes (Table 1 and Table A2 in Appendix 1). The leading cause of all-age years lived with disability was musculoskeletal disorders at 1 035 204, closely followed by mental and substance use disorders at 930 422. In contrast to the age-standardized mortality rate, which decreased between 2006 and 2016, the rate of agestandardized years lived with disability remained relatively stable (+1%). Between 2006 and 2016, the largest decline in rates of age-standardized years lived with disability for level 2 causes occurred for neglected tropical diseases and malaria (-16%), and the largest increase was for neonatal disorders (+25%).
Neoplasms, cardiovascular disease, musculoskeletal disorders, and mental and substance use disorders were the top 4 causes of all-age disability-adjusted life year counts in Canada in 2016, accounting for about 56% of the total 8 824 288 disability-adjusted life years (Table 2 and Table A3 in Appendix 1). Figure 1 shows the rank of all-age cause-specific disability-adjusted life years in 1990, 2006 and 2016. Neoplasms surpassed cardiovascular disease as the top cause of all-age disability-adjusted life years between 1990 and 2006, and these ranks were maintained in 2016. During this period, musculoskeletal disorders surpassed mental and substance use disorders to become the third leading cause of all-age disabilityadjusted life years. The rate of all-cause, age-standardized disability-adjusted life years decreased by 5% between 2006 and 2016, with the rates for only nutritional deficiencies, mental and substance use disorders, and musculoskeletal disorders increasing during this period (Table 2 ). In 1990, 45% of total all-cause disability-adjusted life years were from years lived with disability; this proportion grew to 50% in 2006 and 52% in 2016. This change indicates a shift from premature mortality to morbidity contributing to overall health loss in Canada. As shown in Appendix 2 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180698/-/ DC1), peak age-specific disability-adjusted life years were in the 60-to 64-year age group for both males and females.
Life expectancy and healthy life expectancy at birth across countries with high sociodemographic index
In 2006, Canada's life expectancy at birth -81 years -was ranked eighth among the 21 comparator countries, with life expectancies in this group ranging from 78 years in the US and Denmark to 83 years in Andorra (Table 3 ). In 2016, Canada's life expectancy increased to 82 years, which ranked tenth. In 2006, Canada's health-adjusted life expectancy -70 years -was ranked sixth among the 21 countries with a high sociodemographic index; in 2016, Canada ranked seventh with a healthadjusted life expectancy of 71 years.
Interpretation
We identified several important findings in this study. All-age mortality is increasing, but age-standardized mortality is declining across most causes. This pattern reflects an aging population combined with improved population health. In addition, there is a general shift in the burden of health loss from premature mortality to disability, as shown by years lived with disability accounting for 52% of total disability-adjusted life years in 2016, a proportion that increased from 45% in 1990. Rankings in causespecific all-age disability-adjusted life years seem to have stabilized in recent years, with only minor changes in the rankings of level 2 GBD causes between 2006 and 2016. Finally, improved population health has translated into gains in life expectancy and health-adjusted life expectancy that have kept pace with those of other high-income countries.
We have highlighted notable reductions in age-standardized disability-adjusted life years, mortality and years of life lost for cardiovascular diseases, reductions that were larger than those seen for neoplasms. As a result, cardiovascular diseases are now the second leading cause of disease burden in Canada, consistent with findings for some other high-income countries. 18 In contrast, increasing age-standardized rates for mental and substance use disorders were observed for all measures of burden. Mortality associated with drug use disorders was a primary contributor to this increase. This trend is likely to continue, given the large increases observed in opioid-related mortality in Canada in 2016 and 2017, 19, 20 similar to trends observed in the US. 21 Between 2006 and 2016, musculoskeletal disorders had a higher disability burden than mental and substance use disorders, and were the leading cause of years lived with disability and the third leading cause of all-age disability-adjusted life years, similar to a global pattern. 22 Overall, the burden of disease in Canada is shifting from premature mortality, measured by years of life lost, to a greater burden resulting from years lived with disability. This shift is consistent with other high-income countries, including the US. 9 Further exploration of changes at levels 3 and 4 of the GBD hierarchy is needed to unpack some of the observed trends, including further exploration of how changing patterns of risk and protective factors influence these patterns.
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Limitations
The estimates presented here were modelled through the GBD Study, and results may differ from those reported by Canada's high-income countries. There has been a shift in the burden of disease from premature mortality to disability. This shift requires careful health system and public health planning, particularly in light of the major demographic changes that will continue to evolve throughout the coming decades.
